- Patient/Guest
- Phlebotomist
- Updates
| Complete Haemogram | |
350 |
|---|
|
To detect the status of General Health. |
||
 |
Synonym | CBC+ESR+Peripheral Smear |
 |
Package Code | CP11111111 |
 |
Package Type | Hematolgoy |
 |
Pre-Package Condition | No special |
 |
Report Availability | 1st Day |
 |
Package Parameter(s) | 34 |
| Package details | Sample Report |
|---|---|
Tests Included |
|
 |
Synonym | CBC+ESR+Peripheral Smear | |
 |
Test Code | CP11111111 | |
 |
Test Category | Hematolgoy | |
 |
Pre-Test Condition | No special | |
 |
Medical History | Share if any | |
 |
Report Availability | 1st Day | |
 |
Specimen/Sample | Blood 2mL EDETA | |
 |
Stability @21-26 deg. C | 6 Hr(s) | |
 |
Stability @ 2-8 deg. C | 1D(s) | |
 |
Stability @ Frozen | NA | |
 |
# Test(s) | 34 | |
 |
Processing Method | Manual & Haematology Analyser | |
|
Introduction: The 17-Hydroxy-Pregnenolone Test measures 17-hydroxypregnenolone, a steroid hormone, to diagnose adrenal gland disorders like congenital adrenal hyperplasia (CAH) or adrenal tumors, causing fatigue, weight changes, or blood pressure issues. Aligned with 2023 Endocrine Society guidelines, it uses immunoassay for high sensitivity, enabling accurate detection of adrenal dysfunction. This test is critical for confirming adrenal disorders, guiding hormone replacement or surgical interventions, and preventing complications like adrenal crisis, improving outcomes in endocrinology. |